Stocks TelegraphStocks Telegraph
Stock Ideas

RPRX Financial Statements and Analysis

NASDAQ : RPRX

Royalty Pharma plc

$30.30
-0.45-1.46%
At Close 4:00 PM
$30.08
-0.22-0.73%
After-Market 04:42 PM
68.03
B+ESG ScoreESG Rating

RPRX FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

RPRX Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue564.69M537.267M567.978M596.00M536.313M
cost of revenue1.654M6.00M583.60M76.513M277.137M
gross profit563.036M531.267M-15.622M519.487M259.176M
gross profit ratio0.9970.989-0.0280.8720.483
research and development expenses500.00K500.00K500.00K1.00M50.50M
general and administrative expenses56.72M54.708M57.652M59.185M57.234M
selling and marketing expenses0292.00K0-185.00K0
selling general and administrative expenses56.72M54.708M57.652M59.00M57.234M
other expenses-227.604M-212.429M-583.60M77.00M-1.707M
operating expenses-170.384M267.637M641.752M-17.00M384.871M
cost and expenses-170.384M267.637M641.752M-17.00M384.871M
interest income17.508M13.381M7.417M6.50M23.436M
interest expense66.506M49.013M44.232M47.00M46.033M
depreciation and amortization137.79M560.00M729.774M1.418M16.507M
ebitda872.864M560.00M39.959M613.00M167.949M
ebitda ratio1.5460.502-0.131.0290.313
operating income735.074M269.63M-73.774M613.00M151.442M
operating income ratio1.3020.502-0.131.0290.282
total other income expenses net71.284M-75.253M69.501M105.00M-6.768M
income before tax806.358M194.377M-4.273M718.00M122.077M
income before tax ratio1.4280.362-0.0081.2050.228
income tax expense092.373M-9.051M223.00M49.963M
net income543.987M102.004M4.778M494.34M72.114M
net income ratio0.9630.190.0080.8290.134
eps1.610.230.0111.110.16
eps diluted1.210.230.0111.110.16
weighted average shs out447.628M451.02M448.623M446.569M448.439M
weighted average shs out dil592.726M596.912M597.479M446.569M601.138M
Graph

RPRX Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents
short term investments
cash and short term investments
net receivables
inventory
other current assets
total current assets
property plant equipment net
goodwill
intangible assets
goodwill and intangible assets
long term investments
tax assets
other non current assets
total non current assets
other assets
total assets
account payables
short term debt
tax payables
deferred revenue
other current liabilities
total current liabilities
long term debt
deferred revenue non current
deferred tax liabilities non current
other non current liabilities
total non current liabilities
other liabilities
capital lease obligations
total liabilities
preferred stock
common stock
retained earnings
accumulated other comprehensive income loss
other total stockholders equity
total stockholders equity
total equity
total liabilities and stockholders equity
minority interest
total investments
total debt
net debt
Graph

RPRX Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
deferred income tax00000
stock based compensation-1.293M681.00K612.00K617.00K581.00K
change in working capital-1.435B719.458M715.454M795.266M-37.023M
accounts receivables1.175M-1.353M178.00K1.266M-2.685M
inventory00002.685M
accounts payables3.62M-6.00K-3.614M4.586M3.787M
other working capital-1.44B720.817M718.89M789.414M-40.81M
other non cash items2.242B-157.951M-47.193M-513.598M487.885M
net cash provided by operating activities694.706M662.152M669.603M777.285M573.52M
investments in property plant and equipment832.712M-746.628M-86.084M-1.002B-451.132M
acquisitions net-2.596M1.17M1.426M6.079M-3.984M
purchases of investments148.455M-203.984M-6.971M-1.992M-451.132M
sales maturities of investments-95.695M101.455M1.44M1.44M451.132M
other investing activites-2.069B-47.962M-88.09M-2.038M4.458M
net cash used for investing activites-1.186B-895.949M-90.189M-998.75M-450.658M
debt repayment-1.462B-1.462B0-350.00M-1.00B
common stock issued000348.404M1.00B
common stock repurchased79.999M-79.999M0-30.20M-140.117M
dividends paid-94.061M-94.943M-93.805M-89.338M-89.751M
other financing activites1.153B-131.624M-119.619M-116.839M-1.13B
net cash used provided by financing activities-322.909M1.155B-213.424M-237.973M-1.359B
effect of forex changes on cash00000
net change in cash-814.592M921.644M365.99M-459.438M-1.237B
cash at end of period950.052M1.765B843.00M477.01M936.448M
cash at beginning of period1.765B843.00M477.01M936.448M2.173B
operating cashflow694.706M662.152M669.603M777.285M573.52M
capital expenditure832.712M-746.628M-86.084M-1.002B-451.132M
free cash flow1.527B-84.476M583.519M-224.954M122.388M
Graph

Frequently Asked Questions

How did Royalty Pharma plc do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, RPRX generated $564.69M in revenue last quarter, while its costs came in at $1.65M.

Last quarter, how much Gross Profit did Royalty Pharma plc report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Royalty Pharma plc reported a $563.04M Gross Profit for the quarter ended Sep 30, 2024.

Have RPRX's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. RPRX incurred -$170.38M worth of Operating Expenses, while it generated $735.07M worth of Operating Income.

How much Net Income has RPRX posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Royalty Pharma plc, the company generated $543.99M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Royalty Pharma plc have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Royalty Pharma plc as of the end of the last quarter was -.

What are RPRX's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, RPRX had Total Net Receivables of -.

In terms of Total Assets and Current Assets, where did Royalty Pharma plc stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of RPRX were -, while the Total Assets stand at -.

As of the last quarter, how much Total Debt did Royalty Pharma plc have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of RPRX's debt was - at the end of the last quarter.

What were RPRX's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, RPRX reported total liabilities of -.

How much did RPRX's Working Capital change over the last quarter?

Working Capital Change for RPRX was -$1.43B over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

RPRX generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. RPRX generated $694.71M of Cash from Operating Activities during its recently reported quarter.

What was RPRX's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. RPRX reported a -$814.59M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph